Zydus Lifesciences gets DCGI approval for Oxemia drug

Mar 07, 2022

Ahmedabad (Gujarat) [India], March 7 : Zydus Lifesciences on Monday said it has received approval from the Drug Controller General of India (DCGI) for...

Zydus and Sun Pharma Sign Licensing Agreement for Co-Marketing of Desidustat, a Critical Treatment for Chronic Kidney Disease Patients in India

Oct 30, 2023

Mumbai (Maharashtra)/ Ahmedabad (Gujarat) [India], October 30: Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as "Zydus") is a discovery-driven, global lifesciences company...

Zydus gets Mexican regulator nod for Desidustat in test management of COVID-19

Jul 06, 2020

Ahmedabad (Gujarat) [India], July 6 : Pharmaceutical major Zydus Cadila said on Monday it has got approval from Mexico's Federal Commission for the Protection...

Zydus seeks DCGI nod for 'Desidustat' oral pill to treat anaemia in kidney patients

Nov 23, 2021

Ahmedabad (Gujarat) [India], November 23 : Pharmaceutical company Zydus Cadila on Tuesday announced that it has submitted its first "New Drug Application (NDA)" to...